BrachyVision Acuros, which uses a technique best described as a 'Grid-Based Boltzmann Solver' (GBBS), is the most significant additional feature of Varian's latest brachytherapy treatment planning software offering, BrachyVision 8.8. The full system will be demonstrated for the first time at GEC-ESTRO.
"We are thrilled to be partnering with Varian Medical Systems in introducing the Acuros technology to the clinic," says Gregory Failla, chief executive officer of Transpire, Inc. "Varian's leading position in the worldwide radiation oncology market ensures that the maximum number of patients will benefit from the improved treatment quality made possible by BrachyVision Acuros."
Todd Wareing, Transpire's chief technology officer, adds, "The release of BrachyVision Acuros marks the culmination of decades of research, first at Los Alamos National Laboratory and then at Transpire, in the development of rapid and accurate alternatives to traditional Monte Carlo based methods."
Brachytherapy is a very well established form of radiotherapy which is used routinely to treat a wide range of cancers, including gynaecological, prostate, head & neck, skin and lung. It is often delivered in combination with external beam radiotherapy.
* Compared to standard techniques using the American Association of Physicists in Medicine TG43 formulism.
Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devic
|SOURCE Varian Medical Systems, Inc.|
Copyright©2009 PR Newswire.
All rights reserved